Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 7, 2004

View Archived Issues

Novel anti-H. pylori agents designed by Kotobuki scientists

ARS presents new prostaglandin FP receptor antagonists and their use

New lipid A analogues with immunosuppressant activity discovered at Sankyo

Pirfenidone effective against cirrhosis in vivo

Phase I study for SPRC-AB01

ConjuChem updates progress of DAC:GLP-1 development

OGX-011 reduces expression of a protein that promotes cell survival in prostate cancer

Nippon Shinyaku grants Ivax license to HMN-214

Good safety profile of the Taxus Express2 stent in clinical trials and postmarketing registries

Mallinckrodt claims radiolabeled D-amino acids for cancer diagnosis and therapy

Two novel series of HDAC inhibitors patented by Fujisawa

Enanta scientists present two new series of erythromycin-based antibiotics

Roche scientists describe new selective GlyT-1 inhibitors

FDA extends review period for MS-325

ZymoGenetics licenses rFactor XIII to Novo Nordisk

Squalamine granted fast track status for wet AMD

Phase I study for Hematide

Santarus launches Zegerid

Triton BioSystems licenses ING-1 antibody from Xoma

Stellar Biotechnologies awarded NCI grant for KLH development

OraDisc A approved for aphthous ulcers

Neupro submitted for approval in U.S., Europe for Parkinson's disease

Fast track designation for MDX-010 in metastatic melanoma

Antiinflammatory agent by Uriach promising for the treatment of IBD

The inhibition of ADAM metalloproteases may present a novel approach for treatment of cancer

Targeting skeletal metastases in prostate cancer

Regulation of tumor angiogenesis and cell survival by integrin-linked kinase

Germany marks first European launch of Raptiva

Infliximab reported to reduce pain associated with Crohn's disease

Degarelix reduces testosterone and PSA levels in prostate cancer patients

Sildenafil and antidepressants improve premature ejaculation

Therapeutic effects and quality of life improvements of darifenacin in overactive bladder patients

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...